427
Views
20
CrossRef citations to date
0
Altmetric
Drug profile

A critical review of the capsaicin 8% patch for the treatment of neuropathic pain associated with diabetic peripheral neuropathy of the feet in adults

, &
Pages 259-266 | Received 02 Dec 2020, Accepted 08 Jan 2021, Published online: 04 Feb 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Wanxia Liang, Yaqi Lan, Chengyu Chen, Mingyue Song, Jie Xiao, Qingrong Huang, Yong Cao, Chi-Tang Ho & Muwen Lu. (2023) Modulating effects of capsaicin on glucose homeostasis and the underlying mechanism. Critical Reviews in Food Science and Nutrition 63:19, pages 3634-3652.
Read now

Articles from other publishers (19)

Yun Gai, Chong Bai, Wei Zhang, Hua Xiao, Jing Xu, Jia Hou & Xiahui Ge. (2023) Nootkatone attenuates airway inflammation in asthmatic mice through repressing ROS-induced NLRP3 inflammasome activation. Biochemistry and Cell Biology 101:6, pages 513-522.
Crossref
Kun Zhu, Lin Wang, TingTing Liao, Wen Li, Jing Zhou, Yaodong You & Jianyou Shi. (2023) Progress in the development of TRPV1 small-molecule antagonists: Novel Strategies for pain management. European Journal of Medicinal Chemistry 261, pages 115806.
Crossref
Han Na Jang & Tae Jung Oh. (2023) Pharmacological and Nonpharmacological Treatments for Painful Diabetic Peripheral Neuropathy. Diabetes & Metabolism Journal 47:6, pages 743-756.
Crossref
Jade I. Basem, Fatoumata N. Bah & Neel D. Mehta. (2023) A Brief Review on the Novel Therapies for Painful Diabetic Neuropathy. Current Pain and Headache Reports 27:9, pages 299-305.
Crossref
James R. Lathrop, Sheldon N. Rosen, Margaret M. Heitkemper & Diana Taibi Buchanan. (2023) Cyclic Vomiting Syndrome and Cannabis Hyperemesis Syndrome. Gastroenterology Nursing 46:3, pages 208-224.
Crossref
Guy H. Hans, Dima Almeshal, Lotte Vanlommel, Ella Roelant, Iris Verhaegen, Elke Smits, Koen Van Boxem, Robert Fontaine & The PELICAN Investigators Team. (2023) Considerations on the Obstacles That Lead to Slow Recruitment in a Pain Management Clinical Trial: Experiences from the Belgian PELICAN (PrEgabalin Lidocaine Capsaicin Neuropathic Pain) Pragmatic Study. Pain Research and Management 2023, pages 1-13.
Crossref
János Tajti, Délia Szok, Anett Csáti, Ágnes Szabó, Masaru Tanaka & László Vécsei. (2023) Exploring Novel Therapeutic Targets in the Common Pathogenic Factors in Migraine and Neuropathic Pain. International Journal of Molecular Sciences 24:4, pages 4114.
Crossref
Joanna Bielewicz, Maciej Kamieniak, Michał Szymoniuk, Jakub Litak, Wojciech Czyżewski & Piotr Kamieniak. (2023) Diagnosis and Management of Neuropathic Pain in Spine Diseases. Journal of Clinical Medicine 12:4, pages 1380.
Crossref
Arpita Paul, Mohit Kumar, Parikshit Das, Nilayan Guha, Mithun Rudrapal & Md. Kamaruz Zaman. (2022) Drug repurposing – A search for novel therapy for the treatment of diabetic neuropathy. Biomedicine & Pharmacotherapy 156, pages 113846.
Crossref
Yuyu Zhu, Zijun Ouyang, Haojie Du, Meijing Wang, Jiaojiao Wang, Haiyan Sun, Lingdong Kong, Qiang Xu, Hongyue Ma & Yang Sun. (2022) New opportunities and challenges of natural products research: When target identification meets single-cell multiomics. Acta Pharmaceutica Sinica B 12:11, pages 4011-4039.
Crossref
Szabolcs László, István Z. Bátai, Szilvia Berkó, Erzsébet Csányi, Ágnes Dombi, Gábor Pozsgai, Kata Bölcskei, Lajos Botz, Ödön Wagner & Erika Pintér. (2022) Development of Capsaicin-Containing Analgesic Silicone-Based Transdermal Patches. Pharmaceuticals 15:10, pages 1279.
Crossref
Jinyu Luo, Dedan Wu, Qianming Wu, Yan Chen, Yong Gan, Meng He, Wenyangming Sun, Yiqin Ai, Qiuping Su, Xiaohua Zou & Dashou Wang. (2022) Lidocaine Ameliorates Diabetic Peripheral Neuropathy in Streptozotocin-Induced Diabetic Rats through Modulating the c-Jun Signaling Pathway. Contrast Media & Molecular Imaging 2022, pages 1-9.
Crossref
N. Strand, C. Wie, J. Peck, M. Maita, N. Singh, J. Dumbroff, V. Tieppo Francio, M. Murphy, K. Chang, D. M. Dickerson & J. Maloney. (2022) Small Fiber Neuropathy. Current Pain and Headache Reports 26:6, pages 429-438.
Crossref
Jessica Knoell, Shashi Chillappagari, Lars Knudsen, Martina Korfei, Ruth Dartsch, Danny Jonigk, Mark P. Kuehnel, Konrad Hoetzenecker, Andreas Guenther & Poornima Mahavadi. (2022) PACS2–TRPV1 axis is required for ER–mitochondrial tethering during ER stress and lung fibrosis. Cellular and Molecular Life Sciences 79:3.
Crossref
Zunaira Qureshi, Murtaza Najabat Ali & Minahil Khalid. (2022) An Insight into Potential Pharmacotherapeutic Agents for Painful Diabetic Neuropathy. Journal of Diabetes Research 2022, pages 1-19.
Crossref
Antonio Alcántara Montero, Sandra Raquel Pacheco de Vasconcelos, Patricia Minerva Hernández Alvarado, Fernando Peñato Tarifa & Mario Tovar Matsuki Martín de Prado. (2022) Presente y futuras perspectivas en el abordaje farmacológico del dolor neuropático. Multidisciplinary Pain Journal.
Crossref
Simona Cernea & Itamar Raz. (2021) Management of diabetic neuropathy. Metabolism 123, pages 154867.
Crossref
Chin-Hong Chang, Ying-Shuang Chang & Yu-Lin Hsieh. (2021) Transient receptor potential vanilloid subtype 1 depletion mediates mechanical allodynia through cellular signal alterations in small-fiber neuropathy. PAIN Reports 6:1, pages e922.
Crossref
Fengxian Li & Fang Wang. 2021. Ion Channels in Biophysics and Physiology. Ion Channels in Biophysics and Physiology 249 273 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.